Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Invasive candidiasis (IC) is an important healthcare-related infection, with increasing incidence and a crude mortality exceeding 50%. Numerous treatment options are available yet comparative studies have not identified optimal therapy. METHODS: We conducted an individual patient-level quantitative review of randomized trials for treatment of IC and to assess the impact of host-, organism-, and treatment-related factors on mortality and clinical cure. Studies were identified by searching computerized databases and queries of experts in the field for randomized trials comparing the effect of ≥2 antifungals for treatment of IC. Univariate and multivariable analyses were performed to determine factors associated with patient outcomes. RESULTS: Data from 1915 patients were obtained from 7 trials. Overall mortality among patients in the entire data set was 31.4%, and the rate of treatment success was 67.4%. Logistic regression analysis for the aggregate data set identified increasing age (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.00-1.02; P = .02), the Acute Physiology and Chronic Health Evaluation II score (OR, 1.11; 95% CI, 1.08-1.14; P = .0001), use of immunosuppressive therapy (OR, 1.69; 95% CI, 1.18-2.44; P = .001), and infection with Candida tropicalis (OR, 1.64; 95% CI, 1.11-2.39; P = .01) as predictors of mortality. Conversely, removal of a central venous catheter (CVC) (OR, 0.50; 95% CI, .35-.72; P = .0001) and treatment with an echinocandin antifungal (OR, 0.65; 95% CI, .45-.94; P = .02) were associated with decreased mortality. Similar findings were observed for the clinical success end point. CONCLUSIONS: Two treatment-related factors were associated with improved survival and greater clinical success: use of an echinocandin and removal of the CVC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Two RCTs have been published (119, 120); one failed to achieve a difference in time-to-antimicrobials between arms (120) and the other found no significant difference in mortality despite a 90-minute difference in median time interval to antimicrobial administration (119).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Source control of infectious foci was associated with improved survival in recent observational and cluster randomized studies (120,263,264).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Treatment with FLC often fails despite isolates being drug susceptible when tested in vitro, and rates of persistent candidemia are often higher in patients treated with FLC rather than with echinocandins 58 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [58]
In the citing paper
“The most recent Infectious Disease Society of America (IDSA)125 and European guidelines126,127 recommend echinocandins as first-line initial treatment for most invasive candidiasis in both neutropenic and non-neutropenic patients prior to identification to the species level due to their broad spectrum of activity, favorable side effect profile, mortality benefit, and the increasing incidence of az”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [130]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 3×
“mon cause of nosocomial bloodstream infection [1–4].”
BackgroundMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Biofilms and Device-Associated Infections
Donlan, R. M. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010226 · Cited by 1,504
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Cited by
Items 301–400 of 804
Single-cell immune checkpoint landscape of PBMCs stimulated with Candida albicans
Deng, W., Su, Z., Liang, P., Ma, Y., Liu, Y., Zhang, K., Zhang, Y., Liang, T., Shao, J., Liu, X., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1942228 · Cited by 29
Agnelli, C., Guimarães, T., Sukiennik, T., Lima, P. R. P., Salles, M. J. C., Breda, G. L., Queiroz‐Telles, F., Magri, M. M. C., Mendes, A. V. A., Camargo, L. F. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9040468 · Cited by 30
Immunotherapy: a potential adjunctive treatment for fungal infection
Kullberg, B. J., van de Veerdonk, F. L., & Netea, M. G. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000105 · Cited by 30
Self-citationIdentification and management of invasive mycoses in internal medicine: a road-map for physicians
Falcone, M., Concia, E., Iori, I., Cascio, G. L., Mazzone, A., Pea, F., Violi, F., & Venditti, M. (2014) · Internal and Emergency Medicine · doi:10.1007/s11739-014-1077-4 · Cited by 30
Contemporary Strategies in the Prevention and Management of Fungal Infections
Koehler, P. A., & Cornely, O. A. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.003 · Cited by 28
Tseng, T.-Y., Chen, T., Ho, C., Lin, P., Chou, C.-H., Tsai, C.-T., Wang, J.-H., Chi, C.-Y., & Ho, M. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.08.015 · Cited by 32
Hu, B., Du, Z., Kang, Y., Zang, B., Cui, W., Qin, B., Fang, Q., Qiu, H., & Li, J. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0594-0 · Cited by 31
Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia
Eschenauer, G. A., Nguyen, M.-H., & Clancy, C. J. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015590838 · Cited by 27
Li, C., Wang, H., Yin, M., Han, H., Yue, J.-F., Zhang, F., Shan, T., Guo, H., & Wu, D. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3744 · Cited by 27
A Comprehensive Overview of Candida albicans as the Leading Pathogen in Vulvovaginal Candidiasis
Srb, N., Talapko, J., Meštrović, T., Fureš, R., Stupnišek, M., Srb, A. M., & Škrlec, I. (2025) · Journal of Fungi · doi:10.3390/jof11090632 · Cited by 31
Puig‐Asensio, M., Fernández‐Ruiz, M., Aguado, J. M., Merino, P., Lora, D., Guinea, J., Martín‐Dávila, P., Cuenca‐Estrella, M., & Almirante, B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00195-16 · Cited by 28
Candida haemulonii complex, an emerging threat from tropical regions?
Françoise, U., Desnos‐Ollivier, M., Govic, Y. L., Sitbon, K., Valentino, R., Peugny, S., Chouaki, T., Mazars, E., Paugam, A., Nicolas, M., et al. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011453 · Cited by 26
Self-citationMilazzo, L., Peri, A. M., Mazzali, C., Grande, R., Cazzani, C., Ricaboni, D., Castelli, A., Raimondi, F., Magni, C. F., Galli, M., et al. (2014) · Mycopathologia · doi:10.1007/s11046-014-9786-9 · Cited by 29
Tsai, M.-H., Hsu, J., Chu, S., Chang, P., Lai, M., Wu, I.-H., Huang, H., Chiang, M., Fu, R.-H., & Lu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01123-6 · Cited by 27
Hirano, R., Sakamoto, Y., Kitazawa, J., Yamamoto, S., & Kayaba, H. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s156633 · Cited by 27
Impact of Obesity in Patients with Candida Bloodstream Infections: A Retrospective Cohort Study
Barber, K. E., Wagner, J. L., Miller, J. M., Lewis, E., & Stover, K. R. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00285-7 · Cited by 26
Kaden, T., Alonso‐Román, R., Akbarimoghaddam, P., Mosig, A. S., Graf, K., Raasch, M., Hoffmann, B., Figge, M. T., Hube, B., & Gresnigt, M. S. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122525 · Cited by 26
DiMondi, V. P., Townsend, M. L., Johnson, M. D., & Durkin, M. J. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1433 · Cited by 25
Ou, H., Lee, T., Chen, Y., & Charbonneau, C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2573-8 · Cited by 26
Mazzanti, S., Brescini, L., Morroni, G., Orsetti, E., Pocognoli, A., Donati, A., Cerutti, E., Münch, C. M., Montalti, R., & Barchiesi, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252165 · Cited by 25
Fungal Biofilms in Human Disease
Williams, C., & Ramage, G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09782-4_2 · Cited by 29
The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies
Zobi, C., & Algül, Ö. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70045 · Cited by 26
Pruitt, H. M., Zhu, J., Riley, S. P., & Shi, M. (2025) · Journal of Fungi · doi:10.3390/jof11030236 · Cited by 26
Pérez‐Pitarch, A., Ferriols‐Lisart, R., Aguilar, G., Ezquer, C., Belda, F. J., & Guglieri-López, B. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.013 · Cited by 25
Wei, S., Wu, T. H., Wu, Y., Ding, M., & Zhu, X. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.017 · Cited by 25
Zając‐Spychała, O., Kampmeier, S., Lehrnbecher, T., & Groll, A. H. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2021.782530 · Cited by 24
Alginate oligosaccharides enhance the antifungal activity of nystatin against candidal biofilms
Powell, L. C., Adams, J. Y. M., Quoraishi, S., Py, C., Oger, A., Gazze, S. A., Francis, L. W., von Ruhland, C. J., Owens, D., Rye, P. D., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1122340 · Cited by 25
Candidaemia in the non-neutropenic patient: A critique of the guidelines
Deshpande, A., Gaur, S., & Bal, A. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.005 · Cited by 26
A rare case of Candida glabrata spondylodiscitis: case report and literature review
Gagliano, M., Marchiani, C., Bandini, G., Bernardi, P., Palagano, N., Cioni, E., Finocchi, M., Bellando-Randone, S., & Pignone, A. M. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.003 · Cited by 25
Campos, M. C., Beltrán, M., Fuentes, N., & Moreno, G. (2018) · Biomédica · doi:10.7705/biomedica.v38i0.3352 · Cited by 29
Kawai, A., Yamagishi, Y., & Mikamo, H. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.05.007 · Cited by 23
Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults
Reinhold, I., Picardi, S., Liss, B., Seidel, D., Stemler, J., Koehler, P. A., Ruegamer, T., Sprute, R., & Cornely, O. A. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00409-8 · Cited by 25
Candidemia in Internal Medicine: Facing the New Challenge
Brescini, L., Mazzanti, S., Morroni, G., Pallotta, F., Masucci, A., Orsetti, E., Montalti, R., & Barchiesi, F. (2022) · Mycopathologia · doi:10.1007/s11046-022-00624-x · Cited by 23
Vargas-Espíndola, L. A., Cuervo, S. I., Enciso-Olivera, J. L., Gómez-Rincón, J. C., Cetina, L. P. J., Sánchez, R., García-Guzmán, K., López-Mora, M. J., Álvarez, C., Cortés, J. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9040400 · Cited by 26
Proline catabolism is a key factor facilitating Candida albicans pathogenicity
Silao, F. G. S., Jiang, T., Bereczky-Veress, B., Kühbacher, A., Ryman, K., Uwamohoro, N., Jenull, S., Nogueira, F., Ward, M., Lion, T., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011677 · Cited by 24
Misas, E., Seagle, E. E., Jenkins, E. N., Rajeev, M., Hurst, S. F., Nunnally, N. S., Bentz, M. L., Lyman, M., Berkow, E. L., Harrison, L. H., et al. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-23 · Cited by 26
Zhou, X., Hilk, A. L., Solis, N. V., Scott, N. E., Beach, A., Soisangwan, N., Billings, C. L., Burrack, L. S., Filler, S. G., & Selmecki, A. M. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01795-7 · Cited by 23
González-Lara, M. F., Torres‐González, P., Cornejo‐Juárez, P., Velázquez-Acosta, C., Martínez‐Gamboa, A., Rangel‐Cordero, A., Bobadilla-del-Valle, M., Ostrosky-Zeichner, L. L., Ponce‐de‐León, A., & Sifuentes‐Osornio, J. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2846-2 · Cited by 24
What Could Be the Role of Antifungal Lock-Solutions? From Bench to Bedside
Imbert, C., & Rammaert, B. (2018) · Pathogens · doi:10.3390/pathogens7010006 · Cited by 27
Peng, Z., & Tang, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.783010 · Cited by 26
Chen, L., Xie, Z., & Jian, J. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s471171 · Cited by 22
Non-Invasive Methods to Diagnose Fungal Infections in Pediatric Patients with Hematologic Disorders
Badiee, P., Hashemizadeh, Z., Ramzi, M., Karimi, M., & Mohammadi, R. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.41573 · Cited by 22
Alfatah, M., Bari, V. K., Nahar, A. S., Bijlani, S., & Ganesan, K. (2017) · Scientific Reports · doi:10.1038/srep40281 · Cited by 24
Kontoyiannis, D. P., Bassetti, M., Nucci, M., Capparella, M. R., Yan, J. L., Aram, J. A., & Hogan, P. A. (2017) · Mycoses · doi:10.1111/myc.12641 · Cited by 22
Velde, G. V., Kucharíková, S., Dijck, P. V., & Himmelreich, U. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.03.007 · Cited by 22
Serological biomarkers of candidemia: a retrospective evaluation of three assays
Dichtl, K., Seybold, U., & Wagener, J. (2018) · Infection · doi:10.1007/s15010-018-1224-3 · Cited by 22
A seven-year surveillance of Candida bloodstream infection at a university hospital in KSA
Al-Musawi, T. S., Alkhalifa, W., Alasaker, N. A., Rahman, J. U., & Alnimr, A. M. (2020) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2020.12.002 · Cited by 24
Zhao, L., Yin, W., Sun, Y., Sun, N., Tian, L., Zheng, Y., Zhang, C., Zhao, S., Su, X., Zhao, D., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113715 · Cited by 22
Participation of the ABC Transporter CDR1 in Azole Resistance of Candida lusitaniae
Borgeat, V., Brandalise, D., Grenouillet, F., & Sanglard, D. (2021) · Journal of Fungi · doi:10.3390/jof7090760 · Cited by 24
Fisher, B. T., Vendetti, N., Bryan, M. W., Prasad, P. A., Localio, A. R., Damianos, A., Coffin, S. E., Bell, L. M., Walsh, T. J., Gross, R., et al. (2015) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv048 · Cited by 23
Lee, W., Hsu, J., Lai, M., Chiang, M., Lin, H.-C., Huang, H., Wu, I.-H., Chu, S., Fu, R.-H., & Tsai, M.-H. (2018) · American Journal of Infection Control · doi:10.1016/j.ajic.2018.05.015 · Cited by 23
Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock
Papadimitriou‐Olivgeris, M., Battistolo, J., Poissy, J., Coste, A. T., Bochud, P., Calandra, T., Senn, L., & Lamoth, F. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac383 · Cited by 21
Tang, N., Yuan, S., Luo, Y., Wang, A.-J., Sun, K., Liu, N., & Tao, K. (2023) · ACS Omega · doi:10.1021/acsomega.2c07740 · Cited by 21
Elalouf, A., Elalouf, H., & Rosenfeld, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1292625 · Cited by 24
Badrane, H., Nguyen, M. H., & Clancy, C. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02711-15 · Cited by 22
Impact of an antifungal stewardship intervention on optimization of candidemia management
Winders, H. R., Wagner, J. L., King, S. T., Barber, K. E., & Stover, K. R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117745267 · Cited by 22
Lin, K., Chen, P., Chuang, Y., Wang, J., Sun, H., Sheng, W., Chen, Y., & Chang, S. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.05.011 · Cited by 24
Pietrobom, P. M. P., & Colombo, A. L. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000684 · Cited by 22
Poth, J. M., Schewe, J., Putensen, C., & Ehrentraut, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071940 · Cited by 21
Nucci, M., Colombo, A. L., Petti, M., Magaña, M., Abreu, P. C., Schlamm, H. T., & Sanchez, S. P. (2013) · Mycoses · doi:10.1111/myc.12094 · Cited by 21
Activity of Caffeic Acid Phenethyl Ester in Caenorhabditis Elegans
Coleman, J. J., Komura, T., Munro, J., Wu, M. P., Busanelli, R. R., Koehler, A. N., Thomas, M., Wagner, F. F., Holson, E. B., & Mylonakis, E. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0085 · Cited by 22
Alobaid, K., & Khan, Z. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.12.001 · Cited by 23
Gold, J. A. W., Seagle, E. E., Nadle, J., Barter, D. M., Czaja, C. A., Johnston, H., Farley, M. M., Thomas, S., Harrison, L. H., Fischer, J., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab512 · Cited by 20
Sedik, S., Egger, M., Wolfgruber, S., Salmanton‐García, J., Bassetti, M., Mikulska, M., Özenci, V., Arıkan-Akdağlı, S., Akova, M., Gangneux, J., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106629 · Cited by 22
Ito‐Takeichi, S., Niwa, T., Fujibayashi, A., Suzuki, K., Ohta, H., Niwa, A., Tsuchiya, M., Yamamoto, M., Hatakeyama, D., Suzuki, A., et al. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12809 · Cited by 22
Sakai, D., Matsumiya, W., Kusuhara, S., & Nakamura, M. (2021) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-021-00248-0 · Cited by 21
Glöckner, A., & Cornely, O. A. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02208.x · Cited by 21
Synthesis and Antifungal Activity of Derivatives of 2- and 3-Benzofurancarboxylic Acids
Hejchman, E., Ostrowska, K., Maciejewska, D., Kossakowski, J., & Courchesne, W. E. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196980 · Cited by 20
Nemer, S., Imtiaz, T., Varikkara, M., Collier, A., & Bal, A. M. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2019.1606436 · Cited by 21
Chromatin Structure and Drug Resistance in Candida spp.
O’Kane, C. J., Weild, R., & M. Hyland, E. (2020) · Journal of Fungi · doi:10.3390/jof6030121 · Cited by 18
Lee, A., Wang, N., Carter, C. L., Zimmerman, M., Dartois, V. A., Shaw, K. J., Perlin, D. S., & Zhao, Y. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02476-20 · Cited by 21
T2Candida Assay in the Diagnosis of Intraabdominal Candidiasis: A Prospective Multicenter Study
Krifors, A., Ullberg, M., Castegren, M., Petersson, J., Sparrelid, E., Hammarström, H., Sjölin, J., Özenci, V., & Blennow, O. (2022) · Journal of Fungi · doi:10.3390/jof8010086 · Cited by 23
Enamel Based Composite Layers Deposited on Titanium Substrate with Antifungal Activity
Iconaru, S. L., Prodan, A. M., Turculeţ, C. Ş., Beuran, M., Ghiţă, R. V., Costescu, A., Groza, A., Chifiriuc, M. C., Chapon, P., Gaiaschi, S., et al. (2016) · Journal of Spectroscopy · doi:10.1155/2016/4361051 · Cited by 19
A Risk Score for Fluconazole Failure among Patients with Candidemia
Ostrosky-Zeichner, L. L., Harrington, R. L., Azie, N. E., Yang, H., Li, N., Zhao, J., Koo, V., & Wu, E. Q. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02091-16 · Cited by 19
Significant Publications on Infectious Diseases Pharmacotherapy in 2016
Fong, G. R., Skoglund, E. W., Phe, K., Guastadisegni, J. M., Shea, K. M., McDaneld, P. M., Perez, K. K., & Sofjan, A. K. (2017) · Journal of Pharmacy Practice · doi:10.1177/0897190017727212 · Cited by 21
Jones, T. M., Drew, R. H., Wilson, D. T., Sarubbi, C., & Anderson, D. J. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp170113 · Cited by 20
The impact of age on risk assessment, therapeutic practice and outcome in candidemia
Hesstvedt, L., Gaustad, P., Müller, F., Andersen, C. T., Brunborg, C., Mylvaganam, H., Leiva, R. A., Berdal, J., Ranheim, T. E., Johnsen, B. O., et al. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2019.1595709 · Cited by 21
Sandaradura, I., Marriott, D. J. E., Day, R. O., Norris, R. L. G., Pang, E., STOCKER, S. L., & Reuter, S. E. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04201-w · Cited by 19
Epidemiology of Candidemia in Children over 7 Years in a Medical Center in Turkey
Çiftdoğan, D. Y., Aksay, A. K., Erbaş, G., Sarkış, Ü. B., Öncel, E. K., Anıl, A. B., Baran, M., Er, H., & Yılmaz, N. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00453-21 · Cited by 20
Biofilm Formation as a Pathogenicity Factor of Medically Important Fungi
Vila, T. V. M., & Rozental, S. (2016) · InTech eBooks · doi:10.5772/62768 · Cited by 30
Cutaneous fungal infections in solid organ transplant recipients
Ilyas, M., & Sharma, A. (2017) · Transplantation Reviews · doi:10.1016/j.trre.2017.03.001 · Cited by 22
Bretagne, S., Desnos‐Ollivier, M., Sitbon, K., Lortholary, O., Che, D., Dromer, F., & YEASTS, P. O. T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641965 · Cited by 19
Zhou, X., Hilk, A. L., Solis, N. V., de Sá, N. P., Hogan, B. M., Bierbaum, T. A., Poeta, M. D., Filler, S. G., Burrack, L. S., & Selmecki, A. M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012389 · Cited by 20
Candida auris: A focused review for emergency clinicians
Long, B., Lacy, A. J., Koyfman, A., & Liang, S. Y. (2024) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2024.07.062 · Cited by 18
Miyazaki, T., & Kohno, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1058157 · Cited by 20
Lee, Y., Kim, D. Y., Kim, Y. J., Park, K., & Lee, M. S. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.08.018 · Cited by 18
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients
Coussement, J., Lindsay, J., Teh, B. W., & Slavin, M. A. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000737 · Cited by 18
Lin, C., Liu, C.-P., Hsieh, F.-C., Lee, C.-M., & Wang, W.-S. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.07.007 · Cited by 20
Biofilm: A Robust and Efficient Barrier to Antifungal Chemotherapy
Souza dos Santos, A. L., & de Mello, T. P. (2015) · Journal of Antimicrobial Agents · doi:10.4172/2472-1212.1000e101 · Cited by 19
Pemán, J., Aguilar, G., Valía, J. C., Salavert, M., Navarro, D., & Zaragoza, R. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.12.001 · Cited by 19
Antifungal Clinical Trials and Guidelines: What We Know and Do Not Know
Pappas, P. G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019745 · Cited by 18
Self-citationFazal, F. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.03.12 · Cited by 18
Zaragoza, R., Ferrer, R., Maseda, E., Llinares, P., & Rodríguez, A. H. (2014) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2014.06.001 · Cited by 17
Araujo, J. M., de Almeida, J. N., Magri, M. M. C., Costa, S. F., & Guimarães, T. (2024) · Journal of Fungi · doi:10.3390/jof10040268 · Cited by 18
Thompson, G. R., Chastain, D. B., Ferraz, C., Alhayek, S., Salinas, J. L., Sillau, S., Stenehjem, E. A., & Henao‐Martínez, A. F. (2024) · Medical Mycology · doi:10.1093/mmy/myae122 · Cited by 19
Candidemia in ICU Patients: What Are the Real Game-Changers for Survival?
de Almeida, B. L., Agnelli, C., Guimarães, T., Sukiennik, T., Lima, P. R. P., Salles, M. J. C., Breda, G. L., Queiroz‐Telles, F., Mendes, A. V. A., Camargo, L. F. A., et al. (2025) · Journal of Fungi · doi:10.3390/jof11020152 · Cited by 19
Pasipanodya, J., Hall, R. G., & Gumbo, T. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.38 · Cited by 19
Candidemia in the patient with malignancy
Alves, J., Palma, P., Azevedo, D., & Rello, J. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1508290 · Cited by 19
Tashiro, S., Osa, S., Igarashi, Y., Watabe, Y., Liu, X., Enoki, Y., Taguchi, K., Mayumi, T., Miyazaki, Y., Takesue, Y., et al. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.06.008 · Cited by 19
Neutrophils From Patients With Invasive Candidiasis Are Inhibited by Candida albicans Biofilms
Kernien, J. F., Johnson, C. J., Bayless, M. L., Chovanec, J. F., & Nett, J. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587956 · Cited by 21
Metadata
- Authors
- Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group
- Affiliations
- University of Wisconsin–Madison (US)
- University of Alabama at Birmingham (US)
- The University of Queensland (AU)
- Rutgers, The State University of New Jersey (US)
- AstraZeneca (United States) (US)
- Wayne State University (US)
- Radboud University Nijmegen (NL)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-12
- Volume
- 54
- Issue
- 8
- Pages
- 1110-1122
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2134827411
- Cited by
- 793
- References
- 72
- Citations by year
- 2026: 20 · 2025: 46 · 2024: 46 · 2023: 45 · 2022: 42 · 2021: 64 · 2020: 81 · 2019: 46 · 2018: 71 · 2017: 69 · 2016: 58 · 2015: 62 · 2014: 60 · 2013: 54 · 2012: 28
- FWCI
- 45.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive candidiasis, candidemia, antifungal therapy, echinocandins, central venous catheter removal, mortality, clinical cure, risk factors, immunosuppression, Candida tropicalis, APACHE II score
- MeSH terms
- Adult, Aged, Antifungal Agents, Catheterization, Central Venous, Female, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Echinocandins, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.